Soleus Capital Management’s Pharvaris PHVS Stock Holding History

Soleus Capital Management’s Portfolio PHVS Stock Details PHVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$25.3M	Buy	730,907 +28,855	+4%	+$873K	0.87%	32
2026 Q1	$19.8M	Hold	702,052	–	–	0.8%	33
2025 Q4	$19.5M	Buy	702,052 +55,000	+9%	+$1.32M	0.72%	39
2025 Q3	$16.1M	Sell	647,052 -85,916	-12%	-$1.91M	0.81%	31
2025 Q2	$12.9M	Sell	732,968 -81,684	-10%	-$1.32M	0.85%	33
2025 Q1	$12.8M	Hold	814,652	–	–	0.92%	31
2024 Q4	$15.6M	Buy	814,652 +216,483	+36%	+$4.46M	0.98%	31
2024 Q3	$11.1M	Buy	598,169 +198,739	+50%	+$3.63M	0.86%	38
2024 Q2	$7.51M	Sell	399,430 -2,471	-0.6%	-$50.3K	0.66%	48
2024 Q1	$9.29M	Buy	401,901 +184,505	+85%	+$4.9M	0.69%	44
2023 Q4	$6.1M	Sell	217,396 -126,579	-37%	-$2.56M	0.68%	42
2023 Q3	$7.18M	Sell	343,975 -47,925	-12%	-$883K	0.66%	41
2023 Q2	$5.93M	Buy	391,900 +55,000	+16%	+$532K	0.66%	44
2023 Q1	$2.71M	Buy	336,900 +26,900	+9%	+$237K	0.28%	61
2022 Q4	$3.49M	Buy	+310,000	New	+$1.63M	0.5%	47

Other funds holding PHVS

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

General Atlantic New York $2.91B AUM 24.21% 1-Year Est. Return

FCMI

Foresite Capital Management IV Larkspur, California $290M AUM 143.88% 1-Year Est. Return

venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

EFM

EQT Fund Management Luxembourg $863M AUM 26.03% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

Soleus Capital Management's PHVS Position: Q2 2026 in Review

Soleus Capital Management increased its Pharvaris (PHVS) stake by 4.1% in Q2 2026, buying an estimated $873K and bringing the position to 730,907 shares worth $25.3M. The position accounts for 0.87% of the portfolio, ranked #32.

Soleus Capital Management first reported a position in PHVS in Q4 2022 and has held it in 15 quarters since. 125 funds tracked by Wall St. Rank hold PHVS as of Q2 2026.

Soleus Capital Management held 730,907 shares of Pharvaris worth $25.3M as of Q2 2026.
Soleus Capital Management bought 28,855 Pharvaris shares in Q2 2026, an estimated $873K.
Pharvaris made up 0.87% of Soleus Capital Management's portfolio in Q2 2026, its #32 holding.
Soleus Capital Management first reported a position in Pharvaris in Q4 2022 and has held it in 15 quarters since.
125 funds tracked by Wall St. Rank held Pharvaris as of Q2 2026.

Based on Soleus Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.